Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma

Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma

Background: Current studies have revealed that RNA-binding protein RBM38 is closely related to tumor development, while its role in malignant melanoma remains unclear. Therefore, this research aimed to investigate the function of RBM38 in melanoma and the prognosis of the disease. Methods: Functiona...

Full description

Bibliographic Details
Main Authors: Jinfang Liu, Jun Xu, Binlin Luo, Jian Tang, Zuoqiong Hou, Zhechen Zhu, Lingjun Zhu, Gang Yao, Chujun Li
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
melanoma
RBM38
prognostic signature
tumor microenvironment
immune checkpoint therapy
Online Access:https://www.mdpi.com/2072-6694/14/6/1590

Internet

https://www.mdpi.com/2072-6694/14/6/1590

Similar Items